Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Oct 2016 16:46

RNS Number : 5015M
Sinclair Pharma PLC
13 October 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Sinclair Pharma PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

x

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation:

Soros Fund Management LLC

4. Full name of shareholder(s) (if different from 3.):

Morgan Stanley & Co. LLC

5. Date of the transaction and date onwhich the threshold is crossed orreached:

October 12, 2016

6. Date on which issuer notified:

October 13, 2016

7. Threshold(s) that is/are crossed orreached:

5%

     
 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0033856740

25,000,000

25,000,000

N/A

N/A

25,000,000

N/A

4.97%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

N/A

Below 5%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14. Contact name:

Grace Shin

15. Contact telephone number:

+1 212 320 5554

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMJBATMBIBBIF
Date   Source Headline
5th May 20162:13 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
5th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th May 20163:00 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
4th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd May 201610:51 amPRNForm 8.3 - Sinclair Pharma Plc
3rd May 20167:00 amRNSForm 8.3 - SINCLAIR PHARMA PLC
29th Apr 20165:56 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma REPLACEMENT
29th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
28th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
25th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
22nd Apr 201611:58 amBUSForm 8.3 - Sinclair Pharma Plc
21st Apr 201610:30 amPRNForm 8.3 - Sinclair Pharma Plc
21st Apr 20169:19 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Apr 201611:24 amBUSForm 8.3 - Sinclair Pharma Plc
20th Apr 20168:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Apr 201611:30 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
14th Apr 20161:37 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
13th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
12th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
11th Apr 201610:17 amPRNForm 8.3 - Sinclair Pharma Plc
11th Apr 20169:13 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
8th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC)
7th Apr 20162:19 pmRNSForm 8.3 - [Sinclair Pharma plc]
7th Apr 201611:58 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
6th Apr 20162:34 pmRNSForm 8.3 - [Sinclair Pharma plc]
6th Apr 20169:34 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
5th Apr 20162:49 pmRNSForm 8.3 - [Sinclair Pharma plc]
5th Apr 20169:18 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Apr 20162:51 pmRNSForm 8.3 - [Sinclair Pharma plc]
4th Apr 201610:26 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
1st Apr 20163:44 pmRNSForm 8.3 - [Sinclair Pharma plc]
1st Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
31st Mar 20161:09 pmRNSForm 8.3 - [Sinclair Pharma plc]
31st Mar 201610:54 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
30th Mar 201610:31 amPRNForm 8.3 - Sinclair Pharma Plc
30th Mar 201610:00 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
30th Mar 20167:00 amRNSHalf Yearly Report
30th Mar 20167:00 amRNSAmendment to AQTIS Acquisition Contract Agreed
29th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Mar 201611:21 amPRNForm 8.3 - Sinclair Pharma plc
24th Mar 20161:21 pmRNSNotice of Results
24th Mar 201610:20 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
23rd Mar 201610:22 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
22nd Mar 20163:03 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
22nd Mar 20169:24 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Mar 201611:05 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Mar 20165:39 pmRNSRobert Stuart Swanson - Form 8.3 - Sinclair Pharma

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.